Top Industry Leaders in the Cell Viability Assays Market
Latest Cell Viability Assays Companies Update:
Thermo Fisher Scientific (US) acquired Pheno Therapeutics (US): This move strengthens Thermo Fisher's presence in the cell viability assays market by granting access to Pheno Therapeutics' expertise in high-throughput antibody screening.
Creative Biolabs (US) partners with Absea (France): This partnership expands Creative Biolabs' offerings by offering a comprehensive range of pre-clinical research services, including custom monoclonal antibody development for cell viability assays.
Promega Corporation (US) launched the CellSensor™ Green Fluorescence Live Cell Viability Assay: This new assay offers a simple and rapid method for measuring cell viability using a fluorescence microscope, making it ideal for high-throughput screening applications.
Sartorius Stedim Biotech (Germany) unveiled the IncuCyte S3 Live-Cell Analysis System: This advanced system provides real-time monitoring of cell viability and function through its imaging and analysis capabilities, enabling researchers to gain deeper insights into cell behavior.
Roche (Switzerland) introduced the xCELLigence Real-Time Cell Monitoring System: This label-free platform offers continuous monitoring of cell viability and behavior, providing researchers with a valuable tool for studying cellular responses in real-time.
List of Cell Viability Assays companies in the market
- Thermo Fisher Scientific
- Merck KGaA
- Bio-Rad Laboratories
- GE Healthcare
- Danaher Corporation
- Becton Dickinson & Company
- Promega Corporation
- Biotium
- Abcam plc
- Creative Bioarray